CORRESPONDENCE: RESEARCH CORRESPONDENCE
Heritability of Left Ventricular Mass and Other Morphologic Variables in Caribbean Hispanic Subjects: The Northern Manhattan Family Study
Suh-Hang Hank Juo, MD, PhD,
Marco R. Di Tullio, MD*,
Hsiu-Fen Lin, MD,
Tanja Rundek, MD, PhD,
Bernadette Boden-Albala, MPH, DrPH,
Shunichi Homma, MD and
Ralph L. Sacco, MD, MS
* Division of Cardiology, PH 3-342, Columbia-Presbyterian Medical Center, 630 West 168th Street, New York, NY 10032 (Email: md42{at}columbia.edu).
To the Editor: Left ventricular (LV) hypertrophy is a risk factor for cardiovascular disease (1–3) and ischemic stroke (4–6). Current data suggest that genetic factors and traditional cardiovascular risk factors contribute to left ventricular mass (LVM) and LV hypertrophy. Several studies demonstrated substantial genetic contribution to LVM in white, black, and American Indian populations (7–12). However, no data exist on heritability of LVM in Hispanic patients.
Echocardiographically derived LVM has been validated by comparison with autopsy data (13). From LVM and relative wall thickness (RWT), three abnormal geometric patterns (i.e., concentric hypertrophy, eccentric hypertrophy, and concentric remodeling) (14) can be derived, and they appear to carry different risks for cardiovascular events (6).
In the current study, we tested for the significance of heritability for several LVM-related phenotypes in the high-risk Caribbean Hispanic families from the ongoing Northern Manhattan Family Study (NOMAFS). The detailed ascertainment scheme has been described elsewhere (15). Transthoracic echocardiography was performed according to the guidelines of the American Society of Echocardiography (16). Left ventricular end-diastolic diameter (LVDD), left ventricular end-systolic diameter (LVSD), interventricular septum (IVS), and posterior wall thickness (PWT) at end diastole were measured. To minimize variability, we took measurements in triplicate and averaged them.
Left ventricular mass was calculated from the corrected American Society of Echocardiography method (13): LVM = 0.8 (1.04 [(LVDD + IVS + PWT)3 – LVDD3]) + 0.6. Heritability of LVM also was assessed after correction for the indices of body size most commonly used in published reports: body surface area (LVM/BSA), height (LVM/HT), and height to the 2.7 power (LVM/HT2.7). The heritability of LVDD, LVSD, IVS, PWT, and RWT also was assessed. Relative wall thickness was calculated according to two formulas: (IVS + PWT)/LVDD and 2·PWT/LVDD (14). Echocardiographic studies were interpreted by researchers who were blinded to the clinical characteristics. Interobserver variability ranged between 8% and 10%.
All the quantitative phenotypes were expressed as the mean and standard deviation. Log transformations were used for non-normally distributed variables. We used the Sequential Oligogenic Linkage Analysis Routines (SOLAR) package (Southwest Foundation for Biomedical Research, San Antonio, Texas) (17) to estimate heritability. Ascertainment correction was performed for families that were enrolled based on probands' LVM/BSA  75%.
The current study consisted of 623 subjects from 84 families. The mean family size and age were 11 (range, 3 to 53) subjects and 47 (range, 18 to 95) years, respectively. Men comprised 37% of the total. Mean systolic blood pressure (SBP) was 122.1 ± 19.8 mm Hg. Mean body weight was 76 kg, and average height was 162 cm. The prevalence of diabetes, hypertension, and antihypertensive treatment was 14.2%, 40.6%, and 34.5%, respectively. Means and standard deviations of LV parameters are shown in Table 1. The estimates of heritability for the nine LV phenotypes ranged from 0.49 to 0.23 (all p values  0.001, except p = 0.002 for LVDD) after adjusting for demographic and cardiovascular risk factors (Table 1). Left ventricular mass had the highest heritability and LVDD the lowest in model 3.
We calculated heritabilities for LVM and LV morphologic parameters while adjusting for different combinations of covariates. The results showed substantial heritabilities for all the phenotypes, with LVM having the strongest heritability. Age, gender, weight, and height accounted for the majority of interindividual variation for LV phenotypes. Additional adjustment for SBP, diabetes, and antihypertensive medication almost yielded the same results. Similar to previous reports (12,18), our data showed weight as the most important single predictor of LVM (explained  20% of LVM variance). Relative wall thickness showed weaker heritability than LVM, suggesting that LV geometry may be more strongly affected by acquired conditions, such as blood pressure variability and other unknown exposures. The age- and sex-adjusted heritability comprises common genes with pleiotropic effects on risk factors for LV phenotypes, as well as unique genes for LV phenotypes. Further adjustment for other covariates helps remove the genetic factors exerting pleiotropic effects on these known risk factors. The persistently significant heritabilities suggested a substantial genetic influence on LV phenotypes. To our knowledge, no heritability information was available in Hispanic patients, especially those of Caribbean origin. The present study suggests that genetic factors contributing to LVM and its related phenotypes may have similar and, possibly stronger, heritability in Caribbean Hispanic patients as in other race-ethnic subgroups.
The Strong Heart Study (SHS) analyzed heritability in mostly sibling data collected from 13 American Indian tribes in different geographic locations (7). They reported significant but smaller estimates of adjusted heritability than ours (Table 2). Dividing their participants into three SHS centers, Bella et al. (7) found no significant heritability in relative pairs from Arizona. The SHS investigators suspected that the Arizona Indians are a more homogenous population, which may segregate fewer genetic polymorphisms influencing LV parameters. Using white twin pairs recruited from the general population, Swan et al. (8) reported substantial unadjusted heritabilities of LVM and LV geometric data (Table 2). Adjustment for age, gender, blood pressure, and weight reduced the estimate of heritability from 0.69 to 0.53 for LVM (no adjusted heritabilities for other parameters were reported). Mayosi et al. (9) showed lower heritabilities in white families ascertained through hypertensive probands (Table 2). Garner et al. (10) presented adjusted heritability of 0.28 for LVM in white European nuclear families. Using the correlation between relative pairs, Post et al. (12) estimated adjusted heritability of approximately 0.30 for LVM in the Framingham Heart Study. Analyzing data among hypertensive siblings, the HyperGEN study found that African American subjects had higher sibling correlation in LVM compared with white subjects (11) but that white subjects had a higher correlation in RWT than did African American subjects. However, no heritability was presented in their study.
Unlike most previous studies, we assessed the heritability of LVM after correction by the three most commonly used indices of body size. The estimates of heritability of LVM were not significantly affected by the type of indexing chosen, especially for model 3, with the greatest number of covariates (Table 1). This observation suggests that no single body size index appears preferable in studies on adult populations similar to ours. Adjustment for covariates other than body size, age, and gender had almost no influence on estimates of heritability in models 2 and 3.
More than 40% of our subjects were hypertensive, and 34.5% were taking antihypertensive medication. In our models, adjusting for SBP and antihypertensive medication did not appreciably influence the estimates of heritability after accounting for age, gender, weight, and height. Furthermore, excluding all participants taking antihypertensive medications had little effect on heritability estimations, although it yielded less significant p values (data not shown). Therefore, the effect of hypertension and antihypertensive medication may not be substantial in our study.
In summary, our study indicated that significant genetic factors influence the familial resemblance of LVM in the Caribbean Hispanic population. The considerable estimates of heritability provide the basis for our long-term goal of NOMAFS to map and detect genetic variants contributing to LVM and its related phenotypes.
 |
Acknowledgments
|
|---|
The authors thank Robert Sciacca, EngScD, for assistance in data analysis.
|
Footnotes
|
|---|
Please note: this work was supported by grants from the NINDS R01 NS40807 (to Drs. Juo, Sacco, Boden-Albala, Di Tullio, and Homma) and R01 NS047655 (to Drs. Juo and Sacco). Dr. Di Tullio was supported by a NINDS Mid-Career Investigator Award in Patient-Oriented Research (K24 NS02241). Dr. Lin is supported by the Kaohsiung Medical University fellowship training grant.
|
References
|
|---|
1. Ghali JK, Liao Y, Cooper RS. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease J Am Coll Cardiol 1998;31:1635-1640.[Abstract/Free Full Text]
2. Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men Ann Intern Med 1986;105:173-178.[Abstract/Free Full Text]
3. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 1990;322:1561-1566.[Abstract]
4. Shaper AG, Phillips AN, Pocock SJ, Walker M, Macfarlane PW. Risk factors for stroke in middle aged British men BMJ 1991;302:1111-1115.[Abstract/Free Full Text]
5. Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohortThe Framingham Heart Study. JAMA 1994;272:33-36.[Abstract/Free Full Text]
6. Di Tullio MR, Zwas DR, Sacco RL, Sciacca RR, Homma S. Left ventricular mass and geometry and the risk of ischemic stroke Stroke 2003;34:2380-2384.[Abstract/Free Full Text]
7. Bella JN, MacCluer JW, Roman MJ, et al. Heritability of left ventricular dimensions and mass in American Indians: the Strong Heart Study J Hypertens 2004;22:281-286.[Web of Science][Medline]
8. Swan L, Birnie DH, Padmanabhan S, Inglis G, Connell JM, Hillis WS. The genetic determination of left ventricular mass in healthy adults Eur Heart J 2003;24:577-582.[Abstract/Free Full Text]
9. Mayosi BM, Keavney B, Kardos A, et al. Electrocardiographic measures of left ventricular hypertrophy show greater heritability than echocardiographic left ventricular mass Eur Heart J 2002;23:1963-1971.[Abstract/Free Full Text]
10. Garner C, Lecomte E, Visvikis S, Abergel E, Lathrop M, Soubrier F. Genetic and environmental influences on left ventricular massA family study. Hypertension 2000;36:740-746.[Abstract/Free Full Text]
11. Arnett DK, Hong Y, Bella JN, et al. Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN studyHypertension Genetic Epidemiology Network. Am J Hypertens 2001;14:1226-1230.[CrossRef][Web of Science][Medline]
12. Post WS, Larson MG, Myers RH, Galderisi M, Levy D. Heritability of left ventricular mass: the Framingham Heart Study Hypertension 1997;30:1025-1028.[Abstract/Free Full Text]
13. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 1986;57:450-458.[CrossRef][Web of Science][Medline]
14. Wachtell K, Bella JN, Liebson PR, et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study Hypertension 2000;35:6-12.[Abstract/Free Full Text]
15. Juo SH, Lin HF, Rundek T, et al. Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family Study Stroke 2004;35:2243-2247.[Abstract/Free Full Text]
16. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 1978;58:1072-1083.[Abstract/Free Full Text]
17. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees Am J Hum Genet 1998;62:1198-1211.[CrossRef][Web of Science][Medline]
18. Verhaaren HA, Schieken RM, Mosteller M, Hewitt JK, Eaves LJ, Nance WE. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia twin study) Am J Cardiol 1991;68:661-668.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
|
|
|
|
 
B. M. Mayosi, P. J. Avery, M. Farrall, B. Keavney, and H. Watkins
Genome-wide linkage analysis of electrocardiographic and echocardiographic left ventricular hypertrophy in families with hypertension
Eur. Heart J.,
February 2, 2008;
29(4):
525 - 530.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Sacco
The 2006 William Feinberg Lecture: Shifting the Paradigm From Stroke to Global Vascular Risk Estimation
Stroke,
June 1, 2007;
38(6):
1980 - 1987.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
Top
References